SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-21-181486
Filing Date
2021-06-03
Accepted
2021-06-03 17:16:01
Documents
2
Group Members
BETA OPERATORS FUND, L.P.PARAG SAXENAVEDANTA ASSOCIATES, L.P.VEDANTA ASSOCIATES-R, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d184962dsc13da.htm SC 13D/A 109492
2 EX-99.1 d184962dex991.htm EX-99.1 7658
  Complete submission text file 0001193125-21-181486.txt   118925
Mailing Address 540 MADISON AVENUE, 38TH FLOOR NEW YORK NY 10022
Business Address 540 MADISON AVENUE, 38TH FLOOR NEW YORK NY 10022 212-710-5220
VEDANTA PARTNERS, LLC (Filed by) CIK: 0001502216 (see all company filings)

IRS No.: 261741447 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014 2127105220
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Subject) CIK: 0001742927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90624 | Film No.: 21993550
SIC: 2834 Pharmaceutical Preparations